Prevention of delayed graft function in cadaveric kidney transplants by the calcium antagonist diltiazem and the prostacyclin-analogue iloprost--outcome of a prospective randomized clinical trial.
Neumayer
H H
HH
Department of Internal Medicine and Nephrology, Steglitz Medical Center, Free University of Berlin, FRG.
Schreiber
M
M
Wagner
K
K
D058186:Acute Kidney Injury / Q000503:physiopathology / Q000517:prevention & control; D000328:Adult; D004110:Diltiazem / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D011464:Epoprostenol / Q000008:administration & dosage / Q000627:therapeutic use*; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D016285:Iloprost; D016030:Kidney Transplantation / Q000502:physiology*; D008875:Middle Aged; D011446:Prospective Studies; D012079:Renal Circulation / Q000187:drug effects
D011464:Epoprostenol; D004110:Diltiazem; D016285:Iloprost